194 related articles for article (PubMed ID: 37115691)
1. iPSC-derived retinal pigmented epithelial cells from patients with macular telangiectasia show decreased mitochondrial function.
Eade KT; Ansell BRE; Giles S; Fallon R; Harkins-Perry S; Nagasaki T; Tzaridis S; Wallace M; Mills EA; Farashi S; Johnson A; Sauer L; Hart B; Diaz-Rubio ME; Bahlo M; Metallo C; Allikmets R; Gantner ML; Bernstein PS; Friedlander M
J Clin Invest; 2023 May; 133(9):. PubMed ID: 37115691
[TBL] [Abstract][Full Text] [Related]
2. Genetic disruption of serine biosynthesis is a key driver of macular telangiectasia type 2 aetiology and progression.
Bonelli R; Ansell BRE; Lotta L; Scerri T; Clemons TE; Leung I; ; Peto T; Bird AC; Sallo FB; Langenberg C; Bahlo M
Genome Med; 2021 Mar; 13(1):39. PubMed ID: 33750426
[TBL] [Abstract][Full Text] [Related]
3. Serine biosynthesis defect due to haploinsufficiency of PHGDH causes retinal disease.
Eade K; Gantner ML; Hostyk JA; Nagasaki T; Giles S; Fallon R; Harkins-Perry S; Baldini M; Lim EW; Scheppke L; Dorrell MI; Cai C; Baugh EH; Wolock CJ; Wallace M; Berlow RB; Goldstein DB; Metallo CM; Friedlander M; Allikmets R
Nat Metab; 2021 Mar; 3(3):366-377. PubMed ID: 33758422
[TBL] [Abstract][Full Text] [Related]
4. Anti-retinal IgG antibodies in patients with early and advanced type 2 macular telangiectasia.
McLenachan S; Balaratnasingam C; Heath Jeffery RC; Chen SC; Zhang D; Chan G; Dolz-Marco R; Bacci T; Lo J; Wiffen S; Yannuzzi LA; Chen FK
Exp Eye Res; 2022 May; 218():109024. PubMed ID: 35271830
[TBL] [Abstract][Full Text] [Related]
5. Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy.
Gantner ML; Eade K; Wallace M; Handzlik MK; Fallon R; Trombley J; Bonelli R; Giles S; Harkins-Perry S; Heeren TFC; Sauer L; Ideguchi Y; Baldini M; Scheppke L; Dorrell MI; Kitano M; Hart BJ; Cai C; Nagasaki T; Badur MG; Okada M; Woods SM; Egan C; Gillies M; Guymer R; Eichler F; Bahlo M; Fruttiger M; Allikmets R; Bernstein PS; Metallo CM; Friedlander M
N Engl J Med; 2019 Oct; 381(15):1422-1433. PubMed ID: 31509666
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of cystoid spaces in type 2 idiopathic macular telangiectasia on spectral domain optical coherence tomography images.
Oh JH; Oh J; Togloom A; Kim SW; Huh K
Retina; 2014 Jun; 34(6):1123-31. PubMed ID: 24240556
[TBL] [Abstract][Full Text] [Related]
7. Identification of genetic factors influencing metabolic dysregulation and retinal support for MacTel, a retinal disorder.
Bonelli R; Jackson VE; Prasad A; Munro JE; Farashi S; Heeren TFC; Pontikos N; Scheppke L; Friedlander M; ; Egan CA; Allikmets R; Ansell BRE; Bahlo M
Commun Biol; 2021 Mar; 4(1):274. PubMed ID: 33654266
[TBL] [Abstract][Full Text] [Related]
8. Divergent amino acid and sphingolipid metabolism in patients with inherited neuro-retinal disease.
Green CR; Bonelli R; Ansell BRE; Tzaridis S; Handzlik MK; McGregor GH; Hart B; Trombley J; Reilly MM; Bernstein PS; Egan C; Fruttiger M; Wallace M; Bahlo M; Friedlander M; Metallo CM; Gantner ML
Mol Metab; 2023 Jun; 72():101716. PubMed ID: 36997154
[TBL] [Abstract][Full Text] [Related]
9. Anti-retinal antibodies in patients with macular telangiectasia type 2.
Zhu L; Shen W; Zhu M; Coorey NJ; Nguyen AP; Barthelmes D; Gillies MC
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5675-83. PubMed ID: 23882694
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen Retinopathy and Macular Telangiectasia Type 2: Similarities and Differences on Multimodal Retinal Imaging.
Hess K; Park YJ; Kim HA; Holz FG; Charbel Issa P; Yoon YH; Tzaridis S
Ophthalmol Retina; 2023 Feb; 7(2):101-110. PubMed ID: 35948211
[TBL] [Abstract][Full Text] [Related]
11. Soy Protein Nanofiber Scaffolds for Uniform Maturation of Human Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium.
Phelan MA; Kruczek K; Wilson JH; Brooks MJ; Drinnan CT; Regent F; Gerstenhaber JA; Swaroop A; Lelkes PI; Li T
Tissue Eng Part C Methods; 2020 Aug; 26(8):433-446. PubMed ID: 32635833
[TBL] [Abstract][Full Text] [Related]
12. Systemic lipid dysregulation is a risk factor for macular neurodegenerative disease.
Bonelli R; Woods SM; Ansell BRE; Heeren TFC; Egan CA; Khan KN; Guymer R; Trombley J; Friedlander M; Bahlo M; Fruttiger M
Sci Rep; 2020 Jul; 10(1):12165. PubMed ID: 32699277
[TBL] [Abstract][Full Text] [Related]
13. A connectomics approach to understanding a retinal disease.
Zucker CL; Bernstein PS; Schalek RL; Lichtman JW; Dowling JE
Proc Natl Acad Sci U S A; 2020 Aug; 117(31):18780-18787. PubMed ID: 32699144
[TBL] [Abstract][Full Text] [Related]
14. Perifoveal müller cell depletion in a case of macular telangiectasia type 2.
Powner MB; Gillies MC; Tretiach M; Scott A; Guymer RH; Hageman GS; Fruttiger M
Ophthalmology; 2010 Dec; 117(12):2407-16. PubMed ID: 20678804
[TBL] [Abstract][Full Text] [Related]
15. Modeling of mitochondrial bioenergetics and autophagy impairment in MELAS-mutant iPSC-derived retinal pigment epithelial cells.
Bhattacharya S; Yin J; Huo W; Chaum E
Stem Cell Res Ther; 2022 Jun; 13(1):260. PubMed ID: 35715869
[TBL] [Abstract][Full Text] [Related]
16. Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery.
Eade K; Giles S; Harkins-Perry S; Friedlander M
J Vis Exp; 2021 Mar; (169):. PubMed ID: 33749682
[TBL] [Abstract][Full Text] [Related]
17. FLUORESCENCE LIFETIME PATTERNS IN MACULAR TELANGIECTASIA TYPE 2.
Solberg Y; Dysli C; Wolf S; Zinkernagel MS
Retina; 2020 Jan; 40(1):99-108. PubMed ID: 30664123
[TBL] [Abstract][Full Text] [Related]
18. Base-Resolution Methylome of Retinal Pigment Epithelial Cells Used in the First Trial of Human Induced Pluripotent Stem Cell-Based Autologous Transplantation.
Araki H; Miura F; Watanabe A; Morinaga C; Kitaoka F; Kitano Y; Sakai N; Shibata Y; Terada M; Goto S; Yamanaka S; Takahashi M; Ito T
Stem Cell Reports; 2019 Oct; 13(4):761-774. PubMed ID: 31564644
[TBL] [Abstract][Full Text] [Related]
19. Brain-derived neurotrophic factor levels and macular ganglion cell-inner plexiform layer thickness in macular telangiectasia type 2.
Yu JY; Jeong DE; Joo JY; Kim ST
Int Ophthalmol; 2023 Jun; 43(6):1927-1933. PubMed ID: 36508058
[TBL] [Abstract][Full Text] [Related]
20. Staging of macular telangiectasia: power-Doppler optical coherence tomography and macular pigment optical density.
Chin EK; Kim DY; Hunter AA; Pilli S; Wilson M; Zawadzki RJ; Werner JS; Park SS
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4459-70. PubMed ID: 23716628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
